Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
6,895,036
-
Share change
-
-1,779,293
-
Total reported value
-
$4,232,015
-
Put/Call ratio
-
19%
-
Price per share
-
$0.61
-
Number of holders
-
42
-
Value change
-
-$955,732
-
Number of buys
-
12
-
Number of sells
-
20
Institutional Holders of AMPIO PHARMACEUTICALS INC - COM (AMPE) as of Q3 2017
As of 30 Sep 2017,
AMPIO PHARMACEUTICALS INC - COM (AMPE) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,895,036 shares.
The largest 10 holders included
Knoll Capital Management, LP, VANGUARD GROUP INC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, Noven Financial Group, Inc., GEODE CAPITAL MANAGEMENT, LLC, Carnick & Kubik Group, LLC, GHP Investment Advisors, Inc., NORTHERN TRUST CORP, and Cypress Capital Management LLC (WY).
This page lists
42
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.